Alternative non-antibody protein scaffolds for molecular imaging of cancer

Keyphrases

• Molecular Imaging 100%
• Protein Scaffold 100%
• Antibody Protein 100%
• Clinical Evaluation 50%
• Preclinical Evaluation 50%
• Antibody-based 50%
• Early Detection 50%
• Novel Diagnostics 50%
• Prognostic Biomarker 50%
• Bloodstream 50%
• Molecular Size 50%
• Fibronectin 50%
• Helix 50%
• Chelator 50%
• Biodistribution 50%
• Conserved Regions 50%
• Healthy Tissue 50%
• Diagnostic Agents 50%
• Natural Ligands 50%
• Knottin 50%
• In Vivo Molecular Imaging 50%
• Site-specific Bioconjugation 50%
• Affibody 50%
• DARPin 50%
• Small Protein 50%
• Engineered Protein 50%
• Rational mutation 50%
• High Contrast Image 50%

Biochemistry, Genetics and Molecular Biology

• Clinical Trial 100%
• Molecular Size 100%
• Protein Repeat 100%
• Ankyrin Repeat 100%
• Bioconjugation 100%
• Affibody 100%
• Engineered Proteins 100%
• Biodistribution 100%
• Intravenous Immunoglobulin 100%
• Scaffold Protein 100%
• Ankyrin 100%
• Fibronectin 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Immunoglobulin 100%
• Clinical Trial 33%
• Bioconjugation 33%
• Biological Marker 33%
• Biodistribution 33%
• Scaffold Protein 33%
• Fibronectin 33%
• Diagnostic Agent 33%
• Knottin 33%
• Chelating Agent 33%
• Ankyrin 33%